[Comparative evaluation of neurovirulence of domestic and foreign live mumps vaccine]

Voprosy Virusologii
|November 22, 2001
PubMed

Insights

Researchers studied mumps virus strains in monkeys to assess neurovirulence. The L-3 strain demonstrated lower neurotoxic effects compared to Jeryl Lynn and Urabe Am9, improving vaccine safety evaluations.

Area of Science:

  • Virology
  • Neuroscience
  • Immunology

Background:

  • Mumps virus can cause central nervous system infections.
  • Evaluating the neurovirulence of mumps virus strains is crucial for vaccine safety.
  • Existing methods for assessing neurovirulence may require refinement.

Purpose of the Study:

  • To investigate and compare the neurovirulence of different mumps virus strains.
  • To establish criteria for assessing the neurotoxic potential of mumps virus strains.
  • To evaluate the safety of live mumps vaccines based on strain neurovirulence.

Main Methods:

  • Morphological examination of the central nervous system in infected monkeys.
  • Immunofluorescent analysis to detect viral presence and host response.
  • Quantitative assessment of neurological damage and viral load.

Main Results:

  • Significant differences in neurovirulence were observed among the tested mumps virus strains.
  • The L-3 strain exhibited lower residual neurovirulence compared to the Jeryl Lynn and Urabe Am9 strains.
  • Specific morphological and immunofluorescent changes correlated with the degree of neurovirulence.

Conclusions:

  • The study provides criteria for evaluating mumps virus neurovirulence.
  • The L-3 strain appears to be a safer candidate for live mumps vaccines.
  • Implementing advanced evaluation methods will enhance the safety of mumps vaccines.